Cosentyx belongs to a newer class of drugs that inhibit IL-17, and Novartis is aiming to encourage doctors to use it with longer term data showing that its benefits persist after five years, as ...

It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis, and the Swiss pharma company has new data that it hopes will allow it to compete ...

Some ways to manage psoriasis flare-ups include moisturizing, trying OTC treatments, reducing stress levels, eating an anti-inflammatory diet, and joining a support group, among others. Psoriasis ...

Many common skin care products can help you manage psoriasis, but others can cause irritation and flare-ups of symptoms. This includes products containing alcohol, sulfates, and essential oils ...

Some of its bestselling products include Entresto, a medication used to treat heart failure; Cosentyx, a treatment for psoriasis; and Kesimpta, a treatment for certain forms of multiple sclerosis ...

They can recommend which drug is best for treating your PsA. How does Enbrel compare to other drugs for PsA, such as Cosentyx and Humira? Enbrel, Cosentyx (secukinumab), and Humira (adalimumab ...

2025年最新的临床数据显示，阿达木单抗(Humira)、依那西普(Enbrel)等TNF抑制剂，以及考塞尼汀(Cosentyx)、泰力克Taltz)等IL17抑制剂已成为二线治疗的主要 ...

近期，各大跨国药企相继公布2025年Q1财报。根据各家营收成绩，Q1排名前十依次是：强生、罗氏、默沙东、辉瑞、阿斯利康、艾伯维、诺华、礼来、诺和诺德、BMS，赛诺菲以微弱的差距落于名单之外。同时，肿瘤领域一直是跨国药企的“必争之地”，默沙东的K药 ...

For instance, its two leading blockbusters at present include anti-inflammatory psoriasis and arthritis drug Cosentyx and heart disease treatment Entresto. Share prices have risen more than 20% in ...